Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Fanapt® (iloperidone) – New indication
April 2, 2024 - Vanda Pharmaceuticals announced the FDA approval of Fanapt (iloperidone), for acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
